Group E-5 ‰»Šw\‘’@(Chemical Structure)  

œ
Ethylene oxide iƒGƒ`ƒŒƒ“ƒIƒLƒTƒCƒhG ƒIƒLƒVƒ‰ƒ“GƒGƒ|ƒLƒVƒGƒ^ƒ“G ‚d‚”‚nj@
@@@
CASF 75-21-8@ @Industry@@MW: 44.05
AM Sal. Min (?)
›
1-3)
MB N. crassa
(ƒAƒJƒpƒ“ƒJƒrj
Min (10 mM)
›
4)
PLN Baray (‘ε”ž) ‚»‚Μ‘Ό
Min (?), }S9
›
5, 6)
SLRL Drosophila Min (?)
›
7)
CA Human FL cells Min ( 0.2 mg/ml, -S9)
›
8)
SCEv Monky/LY Min (100 ppm, 7h/d, 5d/w, for 2ys)
›
9)
MNv Mice, BM Min (200 mg/kg, ip) › 10)
DLv Mice Min (300 ppm, 6h/d, 5d/w, for 6w) › 11)
1) Natl. Inst. for Occup. Safety and Health: DHHS) Pub. No 81-130, NTIS Pub. No. PB-85-119-121, Natl Inform. Service, Springfield,
   VA .(May 22, 1981)
2) Embree JW. & Hine CH.,: Toxicol. ‚`ppl. Pharmacol, 33, 172-173 (1975)
3) Hussain S. & Osterman-Gustafsson A.: Chem. Biol. Interact. 12, 265-267 (1976)
4) Kilbey BJ. & Kolmark HG: Mol. Gen. Genet., 101, 185-188(1968)
5) Eherenberg LA., et al.: Hereditas, 45, 351-368 (1959)
6) Jana MK., et al. :Mutation Res., 28, 211-215 (1975)
7) Fahmy OG., et al.: J. Genet., 54, 146-164 (1956)
8) Poirier V. & Papadopoulo D.: Mutation Res., 104, 255-260 (1982)
9
) Kelsey KT., et al.: Cancer Res., 48, 5045 (1988)
10) Canan I., et al., Ann. Fals Exp. Chim., 72, 141-151 (1979)
11) Generoso, WM, et al., Environ. Mol. Mutagen., 16, 126-131 (1990)

IARC Criteria for Carcinogenicity:@
 Group 2A
(Probably carcinogenic)

  yReviewz@IARC Monographs Suppl., 6, pp. 300, Lyon, France (1987)
@
  yNote-1z
(Cited from IARC Monographs, Suppl.., 6 (1987)
@Significant increases in haemoglobin alkylation, in the incidences of CAs and SCEs in peripheral Lym. and, in a single study, MNs in erythrocytes have been observed in workers exposed occupationally to this agent.
@@
   It induced CAs and SCEs in peripheral Lys of monkeys exposed in vivo. It alkylated haemoglobin and DNA and induced CAs, MNs, DL mutations, heritable translocations HT)and SCEs in rodents treated invivo. In human cells in vitro, it induced SCEs, CAs and UDS. It enhanced CT in virus-infected Syr. embryo cells and induced mutation in rodent cells in vitro. It induced somatic and SLRL mutations and HT in Drosophila. It induced mutation and CAs in plants. It was mutagenic to fungi and bacteria and induced DNA damage in bacteria. (IARC Monographs, 11, 157; 36, 189)

yNote-2z@(Cited from CICADs Documents 54  2003)

   The genotoxicity of ethylene oxide has been reviewed extensively (IARC, 1994). Owing to the consistency of the results, only a brief summary of studies conducted with in vitro systems or with Labouratory animals is provided here. Ethylene oxide is a potent alkylating agent that has been genotoxic in virtually all studies in which it was examined (reviewed in IARC, 1994). In in vitro testing, it induced DNA damage and gene mutations in bacteria, yeast, and fungi and gene conversion in yeast. In mammalian cells, observed effects include gene mutations, micronucleus formation, chromosomal aberrations, cell transformation, unscheduled DNA synthesis, sister chromatid exchange, and DNA strand breaks. Notably, Hallier et al. (1993) observed that the frequency of sister chromatid exchange in human peripheral blood lymphocytes exposed in vitro to ethylene oxide was higher in cells isolated from individuals expressing low levels of GSTT1 than in cells from subjects expressing higher levels of this enzyme.

   The results of in vivo studies on the genotoxicity of ethylene oxide have also been consistently positive (see IARC, 1994) following ingestion, inhalation, or injection. In vivo exposure to ethylene oxide induced gene mutation at the hypoxanthine phosphoribosyl transferase (Hprt) locus in mouse and rat splenic T-lymphocytes; sister chromatid exchange was induced in lymphocytes from rabbit, rat, and monkey, in bone marrow cells from mouse and rat, and in rat spleen. Increases in the frequency of gene mutations in the lung (lacI locus) (Sisk et al., 1997) and in T-lymphocytes (Hprt locus) (Walker et al., 1997a) have been observed in transgenic mice exposed to ethylene oxide via inhalation, at concentrations similar to those in carcinogenesis bioassays with this species (NTP, 1987).

   In male Big BlueR (lacI transgenic) B6C3F1 mice exposed to 0, 92, 183, or 366 mg ethylene oxide/m3 for 6 h/day, 5 days/week, for 4 weeks, the observed mean (}SE) frequency of mutation at the Hprt locus in splenic T-lymphocytes was 2.2 (}0.03) ~ 10?6, 3.8 (}0.5) ~ 10?6 (P = 0.009), 6.8 (}0.9) ~ 10?6 (P = 0.001), and 14.1 (}1.1) ~ 10-6 (P < 0.001), respectively (Walker et al., 1997). The frequency of Hprt mutations in splenic T-lymphocytes was increased (compared with unexposed controls) 5.0- to 5.6-fold in male F344 rats and (non-transgenic) male B6C3F1 mice exposed to 366 mg ethylene oxide/m3 for 6 h/day, 5 days/week, for 4 weeks (Walker et al., 1997b). Similarly, the frequency of lacI mutations in the lungs, bone marrow, and spleen, but not in germ cells, was increased in male Big BlueR (lacI transgenic) B6C3F1 mice exposed to 0 or 366 mg ethylene oxide/m3 (Sisk et al., 1997; Recio et al., 1999).
 
   In vivo
exposure to ethylene oxide also induced heritable mutations or effects in germ cells in rodents (IARC, 1994). Ethylene oxide induced dominant lethal effects in mice and rats and heritable translocations in mice. There were dominant visible and electrophoretically detectable mutations in the offspring of male mice exposed (by inhalation) to 366 mg ethylene oxide/m3 for 6 h/day, 5 days/week, for 7 weeks and then mated. This exposure regimen was adopted to ensure that all progeny originated from sperm exposed during the entire spermatogenic process (Lewis et al., 1986). In a study in which male (C3H ~ 101)F1 mice were exposed by inhalation to 0, 302, 373, 458, or 549 mg ethylene oxide/m3, 6 h/day, 5 days/week, for 6 weeks, then daily for an additional 2.5 weeks, and subsequently mated to T-stock (or [SEC ~ 101]F1) females, the percent dominant lethals (P < 0.01 at concentrations >373 mg/m3, compared with controls) was 0 (0), 6 (8), 14 (13), 23 (24), and 60 (45), respectively (Generoso et al., 1990). The frequency of translocation carriers (P < 0.01 at all concentrations, compared with controls) among the progeny of these groups of ethylene oxide-exposed male mice mated to T-stock (or [SEC ~ C57BL]F1) females (data combined) was 1/2068 (0.05%), 32/1143 (2.8%), 52/1021 (5.1%), 88/812 (10.8%), and 109/427 (25.5%), respectively (Generoso et al., 1990).

References
EGeneroso WM, Cain KT, Cornett CV, Cacheiro NLA, Hughes LA (1990) Concentration?response curves for ethylene-oxide-induced heritable translocations and dominant lethal mutations. Environmental and Molecular Mutagenesis, 16: 126-131.
EHallier E, Langhof T, Dannappel D, Leutbecher M, Schroder K, Goergens HW, Muller A, Bolt HM (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Archives of Toxicology, 67: 173-178.
EIARC (1994) Some industrial chemicals. Ethylene oxide. Lyon, International Agency for Research on Cancer, pp. 73?159 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60).
ELewis SE, Barnett LB, Felton C, Johnson FM, Skow LC, Cacheiro N, Shelby MD (1986) Dominant visible and electrophoretically expressed mutations induced in male mice exposed to ethylene oxide by inhalation. Environmental Mutagenesis, 8: 867-872.
ENTP (1987) Toxicology and carcinogenesis studies of ethylene oxide (CAS No. 75-21-8) in B6C3F1 mice (inhalation studies). Research Triangle Park, NC, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program (NTP Technical Report No. 326; NIH Publication No. 88-2582).
ERecio L, Abernethy DJ, Donner M, Pluta L, Preston J (1999) Assessment of the in vivo mutagenicity of ethylene oxide in the bone marrow of B6C3F1 lacI transgenic mice following a chronic inhalation exposure. Toxicologist, 48(1-S): 368.ESisk SC, Pluta LJ, Meyer KG, Wong BC, Recio L (1997) Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutation Research, 391: 153-164.
EWalker VE, Sisk SC, Upton PB, Wong BA, Recio L (1997a) In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutation Research, 392: 211-222.
EWalker VE, Meng Q, Clement NL (1997b) Spectra of mutations in HPRT exon 3 of T-cells from F344 rats and LAC I transgenic and nontransgenic B6C3F1 mice exposed by inhalation to ethylene oxide. Environmental and Molecular Mutagenesis, 29 (S28) :54.


œ Ethylene 1,11-undecanedicarboxylate (
Ethylene brassylate)
    105-95-3@ @Industry@@ 270.37
AM Sal. Max ( 5.0 mg/plate, }S9)
 
1)
1) Ministry of Labour, Japan, Mutagenicity Test Data of Exist. Chem. Subst., JETOC (Ed.), Suppl. pp. 167 (1997) (Tables English)

œ Ethylenimine@@iƒGƒ`ƒŒƒ“ƒCƒ~ƒ“j@@ @
@@@151-56-4@@Industry/Intermediate @@ 43.08
AM Sal. Min ( 10 ƒΚg/plate)
›
1)
MB N. crassa
(ƒAƒJƒpƒ“ƒJƒrj
Min ( 10 mM)
›
2)
YM S. cerevisiae
iy•κ‹Ϋj
(Gene conversion) Min ( 2 x 10-2 M)
›
3)
CA Barley (‘ε”žj Min (1000 ppm)
›
4)
SLRL Drosophila Min (?)
›
5)
1) McCann J., et al.: Proc. Nat. Acad Sci. (USA), 72, 5135-5139 (1975)
2) Ong T. & de Serres FJ.: Mutation Res., 18, 251-258 (1973)
3) Zimmermann FK.: Mutation Res., 11, 327-337 (1969)
4) Wuu KD. & Grant WF.: Ctytologia, 32, 31-41 (1967)
5) IARC Monograph, Vol. 9, pp.37-46, IARC, Lyon, France (1975)

@@

@IARC Criteria for Carcinogenicity:@
@Group 3@
(Not classifiable as to its carcinogenicity to humans)

œ Ethylenethiourea iƒGƒ`ƒŒƒ“ƒ`ƒI”A‘f; 2-ƒCƒ~ƒ_ƒ\ƒŠƒWƒ“ƒ`ƒIƒ“j
@@@ 96-45-7@Pesticide@ 102.15
AM Sal. Max ( 10.0 mg/plate, }S9)
 
1)
AM Sal. Min ( 10.0 mg/plate, }S9) ›w 4)
CA Don Max (?)   4)
SCE V79 Max (?)   4)
CT BHK21cl Min (?), +S9
›
2)
CAv Rat BM Max ( 100 mg/kg x 5)
 
3)
MNv Mice Max ( 6.0 g/kg  x 2), or   5)
SCEv Mice, BM Max (?)   6)
DLv Mice ICR Max ( 0.6 g/kg)
 
3)
SLRLv Drosophila Max ( 3.5 g/kg), or   5)
HMA Mice/Sal. Min ( 6.0 g/kg), or › 5)
1) Teramoto S., et al., Mutation Res., 56, 121-129 (1977)
2) Styles JA., Br. J. Cancer, 37,931-936 (1978)
3) Teramoto S., et al., Mutation Res., 56, 335-340 (1978)
4) Gangolli S, The Dictionary of Subtances and their Effects, 2nd. Ed., The Royal Society of Chemistry (1999)
5) Schupbach, Mutation Res., 56, 111-120 (1977)
6) IPCS, Environ. Health Criteria, 78 (1988)

œ Ethyl ether@iƒGƒ`ƒ‹ƒG[ƒeƒ‹j
@@@
60-29-7@@Industry/Solvent@@ 74.12
AM Sal Max (10 ƒΚg/plate, }S9)
 
1)
1) Waskell LA.: Mutation Res., 57, 141 (1978)

œ Ethyl N-ethylcarbamate
@@
623-78-9@Labouratory@ 117.15
CA CHL/IU Max ( 2.0 mg/ml, -S9), 24, 48h
 
1)
1) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro, LIC, Tokyo (1998) (Tables in English)@

œ N-Ethylethylenediamine (2-Ehylaminoethylamine)
@@
110-72-5@Industry@ 88.15
AM Sal. Max ( 1.0 mg/plate, }S9)
 
1)
1) Ministry of Labour, Japan, Mutagenicity Test Data of Exist. Chem. Subst., JETOC (Ed.), (1996) (Tables in English)

œ
2-Ethyl hexanoic acid @iƒGƒ`ƒ‹ƒwƒLƒTƒ“Ž_j
@@@149-57-5@Industry@ 130.23

AM Sal. Max ( 0 5. mg/plate, }S9)
 
1)
1) Ministry of Labour, Japan, Mutagenicity Test Data of Exist. Chem. Subst., JETOC (Ed.), Suppl., 2 (2000) (Tables in English)

œ 2-Ethyl hexanol @@(Ethylhexanol)
@@@104-76-7 @Industry@ 144.21

AM Sal. Max ( 5.0 mg/plate, }S9)
 
1)
1) Ministry of Labour, Japan, Mutagenicity Test Data of Exist. Chem. Subst., JETOC (Ed.), Suppl., 2 (2000) (Tables in English)

œ 2-Ethylhexyl methacrylate@i2-ƒGƒ`ƒ‹ƒwƒL ƒVƒ‹ƒƒ^ƒAƒNƒŠƒŒ[ƒgGƒƒ^ƒNƒŠƒ‹Ž_-2-ƒGƒ`ƒ‹ƒwƒLƒVƒ‹j
@@@688-84-6@ Industry@@ 198.34
AM Sal./e. coli Max (0.625 mg/plate, }S9)
 
1)
CA CHL/IU Max ( 5.0 mg/ml, }S9), 6-18h
 
1)
1) Ministry of Health & Welfare, Japan (Ed): Tox Test. Rep. of Environ. Chemicals, Vol. 6, pp.399 (1998) (Tables in English)

œ Ethyl p-hydroxybenzoate (Ethyl paraben) (ƒGƒ`ƒ‹ p-ƒqƒhƒƒLƒVƒxƒ“ƒ[ƒ“j
@ @120-47-8@ Food@@ 166.18
CA CHL/IU Max ( 0.25 mg/ml, -S9), 24, 48h
’
1)
1) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro LIC, Tokyo (1998) (Tables in English)@

œ N-Ethyl-N-(4-hydroxybutyl) niotrosamine
@@@54897-62-0@Labouratory@ 146.22
AM Sal. Max (?)
’
1)
CA CHL/IU Max ( 2.0 mg/ml, -S9), 24, 48h
 
2)
1) Natl. Inst. Hygien. Sci., Tokyo ?
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro LIC, Tokyo (1998)  (Tables in English)

œ 2-Ethyl-2-hydroxymethyl-1,3-propanediol
@@77-99-6@Industry@ 134.18
AM Sal/e. coli Max ( 5.0 mg/plate, }S9)
 
1)
CA CHL/IU Max ( 1.34 mg/ml, }S9), 6-18h
 
1)
1) Ministry of Health, Labour & Welfare, Japan (Ed): Toxicity Testing Reports of Environ. Chemicals, Vol. 1 (1994) (Tables in English)

œ 5-Ethylidene-2-norbornene i5-ƒGƒ`ƒŠƒfƒ“-2-ƒmƒ‹[ƒ{ƒ‹ƒlƒ“j
@@
16219-75-3 @Industry @ 120.20
AM Sal./E. coli Max ( 0.5 mg/plate, }S9)
 
1)
CA CHL/IU Max ( 0.1 mg/ml, }S9), 6-18h
 
1)
1) Ministry of Health, Labour & Welfare, Japan (Ed): Toxicity Testing Reports of Environ. Chemicals, Vol. 6 (1998) (Tables in English)

 USA-NTP Genotoxicity Screening :
   ›@Ames Test:@ 

œ Ethyl isovalerate iƒGƒ`ƒ‹ƒCƒ\ƒoƒŒƒŒ[ƒgj
@@108-64-5@Food@@ 1360.19
AM Sal. Max ( 2.0 mg/plate, }S9)
 
1)
CA CHL/IU Max ( 2.0 mg/ml, -S9), 24, 48h
 
2)
1) Ishidate MJr. (Ed.) Data Book of Mutagenicity Tests on Chemicals in Bacteria, LIC/Tokyo (1991) (Tables in English)
2
) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro LIC, Tokyo (1998) (Tables in English)
œTop Page@iƒgƒbƒvƒy[ƒWj
œAbbreviation @iΘ—ͺ‹L†j@
œMutagenicity Testing@i•ΟˆΩŒ΄«ŽŽŒ±j
œTest Systems@(ŽŽŒ±–@‚ΜŽν—ށj
œTechnical Problems@i‹Zp“I–β‘θ“_j
œList of@Compoundsi‰»‡•¨ƒŠƒXƒgj
œEvaluation of Results@iŽŽŒ±Œ‹‰Κ‚Μ•]‰Ώj